Prolia Price in Iraq
Information regarding the specific price of Prolia (denosumab) in Iraq is not readily available through public databases. Drug pricing can vary significantly based on factors such as import costs, local distribution agreements, pharmacy markups, and insurance coverage, if applicable.
How is Prolia Used?
Prolia is a medication prescribed to treat osteoporosis in postmenopausal women at increased risk of fracture, and to treat bone loss in men receiving certain cancer treatments. It is also used to treat bone density loss in individuals with certain types of cancer or those undergoing treatment for bone metastases [1].
How Does Prolia Work?
Prolia is a monoclonal antibody that works by targeting and inhibiting the receptor activator of nuclear factor kappa-B ligand (RANKL). RANKL is a protein that plays a crucial role in the formation, function, and survival of osteoclasts, which are cells responsible for bone resorption (breakdown). By blocking RANKL, Prolia reduces osteoclast activity, thereby decreasing bone breakdown and increasing bone mineral density [1].
What is the Typical Dosage of Prolia?
The standard dose of Prolia for osteoporosis in postmenopausal women and for bone loss in men is 60 mg administered subcutaneously every six months [1]. For other indications, such as bone metastases or giant cell tumor of bone, the dosage and frequency may differ [1].
What Are the Potential Side Effects of Prolia?
Common side effects associated with Prolia include pain in the extremities, muscle pain, and eczema. More serious potential side effects, though less common, can include severe infections, low calcium levels (hypocalcemia), osteonecrosis of the jaw (ONJ), and atypical femur fractures [1]. Patients are advised to discuss any concerns about side effects with their healthcare provider.
Where Can I Find Information on Drug Patents?
Information on drug patents, including expiry dates and any related litigation, can be found on DrugPatentWatch.com. This resource provides a database of patents for pharmaceutical products [2].
How Long Do Drug Patents Typically Last?
In many countries, including the United States, patents for pharmaceutical drugs typically last for 20 years from the date of filing. However, various mechanisms exist that can extend or shorten the effective market exclusivity period, such as patent term extensions to compensate for regulatory review delays or challenges to patent validity [3].
Who Are Prolia's Competitors?
Prolia's primary competitors in the osteoporosis market include other classes of drugs such as bisphosphonates (e.g., alendronate, risedronate, zoledronic acid) and other anabolic agents. Different medications have varying mechanisms of action, administration routes, and efficacy profiles, making them suitable for different patient populations [4].
---
Sources:
[1] https://www.drugs.com/prolia.html
[2] https://www.drugpatentwatch.com/
[3] https://www.drugpatentwatch.com/faq
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085758/